Keigo Kobayashi - Concepedia

Author

Keigo Kobayashi

Also Known As

Joel Armando Vázquez-Pérez, K Kobayashi, K. Kobayashi, K.F. Kobayashi, Keigo KOBAYASHI, Keigo Kobayashi, Massa Shoura, Mitsuaki Kojima, Takashi Inoue, Toshiyuki Hirano

159

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Keio University Kyoto University The University of Osaka Saiseikai Central Hospital Kitasato University

About

Keigo Kobayashi is an author at Keio University specializing in engineering, medicine, and mechanical systems.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	11	11	409
2	Medicine	10	10	249
3	Public Health	2	2	35
4	Health Sciences	1	1	25
5	Natural Sciences	1	1	75

Keigo Kobayashi

Publications

Citations

H-Index

Page 1

	Year	Citations
High Pressure NQR Measurement in CeCu<sub>2</sub>Si<sub>2</sub> up to Sudden Disappearance of Superconductivity Kenji Fujiwara, Yoshiki Hata, Keigo Kobayashi, Journal of the Physical Society of Japan Superconducting MaterialEngineeringNuclear PhysicsBismuth-based SuperconductorsMagnetic Resonance	2008	75
Nonholonomic control of 3 link planar manipulator with a free joint Jun‐ichi Imura, Keigo Kobayashi, T. Yoshikawa Robot KinematicsMotion ControlRobot ControlEngineeringMechatronics	2002	65
Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis Keigo Kobayashi, Ichiro Nakachi, Katsuhiko Naoki, Clinical Lung Cancer MedicineRetrospective Multicenter AnalysisImmune Checkpoint InhibitorReal-world EfficacyCancer Treatment	2018	53
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare <i>EGFR</i> mutations Shinnosuke Ikemura, Hiroyuki Yasuda, Shingo Matsumoto, Proceedings of the National Academy of Sciences	2019	53
IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer Tadashi Manabe, Hiroyuki Yasuda, Hideki Terai, Molecular Cancer Research	2020	52
Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations Hanako Hasegawa, Hiroyuki Yasuda, Junko Hamamoto, Lung Cancer Insertion MutationsCetuximab Combination TherapyNon-small-cell Lung CancerMedicinePathology	2018	50
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong, Nature Communications	2022	48
Discovery of Hexagonal Structured Pd–B Nanocrystals Keigo Kobayashi, Hirokazu Kobayashi, Mitsuhiko Maesato, Angewandte Chemie International Edition Materials SciencePd NcsBoron NitrideEngineeringHexagonal Boron Nitride	2017	44
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers Takashi Sato, Kenzo Soejima, Daisuke Fujisawa, The Oncologist	2018	44
Controllability of Under-Actuated Planar Manipulators with One Unactuated Joint Keigo Kobayashi, Tsuneo Yoshikawa The International Journal of Robotics Research Robot KinematicsMotion ControlRobot ControlUnactuated JointEngineering	2002	43

Page 1